The Metabolomics Core provides comprehensive analytical support for investigators in the diabetes and obesity mouse research community. The focus of the Metabolomics Core will be on providing panels of relevant metabolic measurements, rather than single-point measurements, to clearly assess the consequences of changes in gene expression. An equally important aspect of the Metabolomics Core is the measurement of isotopic enrichment in an array of metabolites. The use of stable isotopes has become an essential component of modern methods to characterize metabolic flux. An important new initiative of the Metabolomics Core is the analysis of concentrations and fluxes of gut microbial-derived metabolites. The services provided by the Metabolomics Core include the extraction, purification, derivatization, and instrumental analysis of metabolites and selected enzyme activities from tissues and plasma. The methods have been scaled to account for the minimal amounts of tissues (~10 to 25 mg, and plasma volumes of ~ 5 to 25 l) that can be provided by investigators. The facility is equipped with an array of state-of-the-art instrumentation, including GC-MS, LC-MS/MS, and NMR, providing the flexibility and resources for analyses of metabolite concentrations as well as isotopic enrichments. Metabolic panels of serum, plasma, and urine, including Chem 7, liver function tests, lipid profiles, and divalent cations, are obtained using the COBAS MIRA system optimized for analysis of the mouse samples such that required volumes average ~20 l of serum for any combination of 4 tests. These plasma chemistry assays fill a need with very high demand for mouse studies, as reflected in our work flow over the last funding period. GC-MS and LC-MS/MS analyses provide complete profiles of chain length distribution of fatty acid metabolites, included free fatty acids, fatty acyl-CoA esters, diacylglycerols, ceramides. Other LC-MS/MS that are offered and are in high-demand include intermediates of glucose metabolism for metabolic flux measurements, and creatinines for renal clearance. The Metabolomics Core is a resource lab for the analysis of samples generated during the course of experiments of the Integrative Physiology Core and the Microbiome and Animal Care Core at the Yale MMPC, and also provides the same array of assays to other outside investigators to assist in phenotyping of transgenic mouse models of diabetes. Samples are analyzed on a fee-for-service basis with the charge per assay based on policy determined by the National MMPC Executive Committee, designed to provide substantial savings to NIH-funded users compared to commercial vendors. The Core has an active Research and Development Program to develop new analytical protocols to address new and exciting developments in the biochemistry of diabetes, obesity, and associated complications.

Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Yale University
Internal Medicine/Medicine
Schools of Medicine
New Haven
United States
Zip Code
Perry, Rachel J; Peng, Liang; Cline, Gary W et al. (2017) A Non-invasive Method to Assess Hepatic Acetyl-CoA In Vivo. Cell Metab 25:749-756
Hwang, Janice J; Jiang, Lihong; Hamza, Muhammad et al. (2017) The human brain produces fructose from glucose. JCI Insight 2:e90508
Ikeda, Kenji; Kang, Qianqian; Yoneshiro, Takeshi et al. (2017) UCP1-independent signaling involving SERCA2b-mediated calcium cycling regulates beige fat thermogenesis and systemic glucose homeostasis. Nat Med 23:1454-1465
Lee, Hui-Young; Lee, Jae Sung; Alves, Tiago et al. (2017) Mitochondrial-Targeted Catalase Protects Against High-Fat Diet-Induced Muscle Insulin Resistance by Decreasing Intramuscular Lipid Accumulation. Diabetes 66:2072-2081
Sharabi, Kfir; Lin, Hua; Tavares, Clint D J et al. (2017) Selective Chemical Inhibition of PGC-1? Gluconeogenic Activity Ameliorates Type 2 Diabetes. Cell 169:148-160.e15
Perry, Rachel J; Peng, Liang; Abulizi, Abudukadier et al. (2017) Mechanism for leptin's acute insulin-independent effect to reverse diabetic ketoacidosis. J Clin Invest 127:657-669
Okin, Daniel; Medzhitov, Ruslan (2016) The Effect of Sustained Inflammation on Hepatic Mevalonate Pathway Results in Hyperglycemia. Cell 165:343-56
Samuel, Varman T; Shulman, Gerald I (2016) The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J Clin Invest 126:12-22
Camell, Christina D; Nguyen, Kim Y; Jurczak, Michael J et al. (2015) Macrophage-specific de Novo Synthesis of Ceramide Is Dispensable for Inflammasome-driven Inflammation and Insulin Resistance in Obesity. J Biol Chem 290:29402-13
Bettaieb, Ahmed; Jiang, Joy X; Sasaki, Yu et al. (2015) Hepatocyte Nicotinamide Adenine Dinucleotide Phosphate Reduced Oxidase 4 Regulates Stress Signaling, Fibrosis, and Insulin Sensitivity During Development of Steatohepatitis in Mice. Gastroenterology 149:468-80.e10

Showing the most recent 10 out of 22 publications